EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases
Details for Australian Patent Application No. 2006301579 (hide)
International Classifications
Event Publications
1 May 2008 PCT application entered the National Phase
PCT publication WO2007/042166 Priority application(s): WO2007/042166
1 March 2012 Application Accepted
Published as AU-B-2006301579
28 June 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006301582-Matrix metalloproteinase 11 vaccine
2006301578-Method for diagnosing thromboembolic disorders and coronary heart diseases
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser